gastric%20cancer
GASTRIC CANCER
Gastric cancer is the cancer originating in the esophagus, esophagogastric junction and stomach.
Most of gastric cancers are adenocarcinomas, subdivided according to histological appearances into diffuse (undifferentiated) and intestinal (well differentiated) types.
It is the 4th most common cancer and the 2nd most common cause of cancer-related deaths worldwide.
Most common sites of gastric cancer are the proximal lesser curvature, cardia and esophagogastric junction.

Introduction

  • Fourth most common cancer & second most common cause of cancer-related deaths worldwide
    • In Japan, this is the most common type of cancer in men
  • Most common sites of gastric cancer are the proximal lesser curvature, cardia & esophagogastric junction

Definition

  • Cancers originating in the esophagus, esophagogastric junction & stomach
  • Most of gastric cancers (90%) are adenocarcinomas, subdivided according to histological appearances into diffuse (undifferentiated) & intestinal (well-differentiated) types (Lauren classification)

Signs and Symptoms

  • Early stage gastric cancer rarely causes symptoms
    • Most commonly diagnosed at an advanced stage
  • Dyspepsia is the early stage symptom
  • Advanced stage signs & symptoms include:
    • Poor appetite
    • Weight loss
    • Dysphagia
    • Abdominal pain
    • Vague abdominal discomfort, usually above the navel
    • A sense of fullness in the upper abdomen after eating a small meal (early satiety)
    • Heartburn or indigestion
    • Nausea & vomiting
    • Swelling or fluid build-up in the abdomen
    • Iron-deficiency anemia

Risk Factors

  • Male
  • Old age (>50 years old)
  • Helicobacter pylori infection
    • Usually the major cause
  • Cigarette/tobacco use
  • Previous gastric surgery eg partial gastrectomy
  • Menetrier’s disease or hypertrophic gastropathy
  • Atrophic gastritis
  • Diet that has large amounts of smoked foods, salted fish & meat & pickled vegetables
    • Nitrates & nitrites on these foods have shown to produce bacteria that causes cancer
  • Stomach lymphoma
  • Pernicious anemia
  • Type A blood
  • Overweight or obesity
  • Inherited cancer syndromes (3-5%) eg hereditary diffuse gastric cancer, hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, breast cancer, Li-Fraumeni syndrome, Peutz-Jeghers syndrome
  • Family history of stomach cancer (5-10%)
  • Epstein-Barr virus
  • Certain occupations eg coal, metal & rubber industry workers
  • Common variable immune deficiency
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elvira Manzano, 6 days ago
Tisagenlecleucel, now US FDA approved, has made history as the first ever chimeric antigen receptor (CAR) T-cell therapy for B-cell precursor acute lymphoblastic leukaemia (ALL) – a breakthrough that has the potential to transform treatment for blood cancers that have not responded to standard therapies.
09 Feb 2017
The combination of previsit patient coaching sessions and a question prompt list (QPL) leads to better patient-oncologist communication in advanced cancer, a study shows.
16 Jun 2015
Anastrozole is more effective than tamoxifen in preventing breast cancer recurrence in postmenopausal women with ductal carcinoma in situ who have undergone lumpectomy and radiation therapy, a recent phase III randomized trial has shown.
Christina Lau, 09 May 2017

Treatment with osimertinib significantly improves symptoms in patients with advanced non-small-cell lung cancer (NSCLC), according to new data from the phase III AURA3 trial presented at the European Lung Cancer Conference (ELCC) 2017.